Delivery Order SPE2DB20D1004-SPE2DB23FF0M9

Award Date 1/5/23
Potential Completion Date 1/6/23
Potential Value $2.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,552.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00, which enables the company to provide a comprehensive range of...
This federal contract award, valued at $2,177.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to manage diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,810.06, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used in the treatment of diabetes. The contract has an ultimate completion date of November 8, 2023, and is structured as a Firm Fixed Price Delivery Order. The contract was awarded on November 7, 2023, and does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,483.11 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,160.82, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used in the treatment of diabetes. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,225.82, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used for the treatment of diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,885.12 firm fixed-price delivery order is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $23,997.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on May 22, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $24,141.59, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 28, 2023. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,335.20 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication used to manage diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF0M9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, worth $2,639.00, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of January 6, 2023 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor, plays a critical role in supplying essential medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 10:19 AM